Garden State Investment Advisory Services’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$207K Sell
589
-100
-15% -$35.6K 0.05% 285
2025
Q4
$226K Buy
+689
New +$219K 0.05% 276
2025
Q2
Sell
-837
Closed -$261K 309
2025
Q1
$261K Buy
837
+15
+2% +$4.43K 0.08% 201
2024
Q4
$214K Buy
822
+79
+11% +$23.4K 0.06% 226
2024
Q3
$239K Sell
743
-1
-0.1% -$327 0.08% 194
2024
Q2
$232K Buy
744
+10
+1% +$2.94K 0.08% 195
2024
Q1
$208K Hold
734
0.08% 206
2023
Q4
$211K Buy
+734
New +$200K 0.08% 195

Other funds holding AMGN

Garden State Investment Advisory Services's AMGN Position: Q1 2026 in Review

Garden State Investment Advisory Services reduced its Amgen (AMGN) stake by 15% in Q1 2026, selling an estimated $35.6K and leaving 589 shares worth $207K. The position accounts for 0.05% of the portfolio, ranked #285.

Garden State Investment Advisory Services first reported a position in AMGN in Q4 2023 and has held it in 8 quarters since. The position peaked at $261K in Q1 2025. 3,130 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Garden State Investment Advisory Services held 589 shares of Amgen worth $207K as of Q1 2026.
  • Garden State Investment Advisory Services sold 100 Amgen shares in Q1 2026, an estimated $35.6K.
  • Amgen made up 0.05% of Garden State Investment Advisory Services's portfolio in Q1 2026, its #285 holding.
  • Garden State Investment Advisory Services first reported a position in Amgen in Q4 2023 and has held it in 8 quarters since.
  • Garden State Investment Advisory Services's Amgen position peaked at $261K in Q1 2025.
  • 3,130 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Garden State Investment Advisory Services's 13F filing for Q1 2026, filed 14 May 2026.